Rebalix
Logo XtrackersXtrackers · sheet of 10 September 2026
ETF sheet · official issuer and register data

Xtrackers Lpx Private Equity Swap UCITS ETF 1c

LU0322250712 · LU0322250712 · EUR · domicile Luxembourg
Equity · GlobalSFDR art. 6 (inferred)
Index tracked: LPX MAJOR MARKET® INDEX (EUR)
TER
0.70%+ trans. 0.00%
Fund size
286 m EUR
Tracking difference
−0.65%3-year avg
🇮🇹 tax rate
white list not published
Replication
Synthetic (swap)
Income
Accumulating
Launch 17 Jan 2008 · costs from the KID as of 2 Sept 2026 · 76 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed. INVESTMENT OBJECTIVE: The aim is for your investment to reflect the performance of the LPX Major Market® index (index) which is designed to reflect the performance of the 25 most frequently traded private equity companies. DESCRIPTION OF INDEX: The main business purpose of the companies must be private equity (which involves investing in companies which are not listed on a stock exchange). The private equity companies themselves must be listed on a stock exchange. The private equity companies may be based in any region…

Performance since series start (in euro) — base 100

17 Jan 20088 Sept 2026 · dividends reinvested where declared by the issuer
20092012201520182021202453826409
High 538 (28 Jan 2025) · low 26 (10 Mar 2009) · last 409. Past performance is not indicative of future results.

Returns in euro

1 year−11.2%
3 years+22.6%
5 years+15.3%
10 years+167.1%
Since series start+309.4%

Risk · 1 / 3 / 5 years

Volatility (ann.)19.94%19.27%22.43%
Max drawdown−25.73%−35.45%−36.76%
Sharpe-0.620.280.14
Sortino-0.810.370.19
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU0322250712 · LU03222507121
RebalixLU0322250712 · LU0322250712 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025−11.86%−11.37%−0.49%
2024+33.05%+33.76%−0.71%
2023+39.99%+40.75%−0.76%
2022−30.03%−29.54%−0.49%
2021+63.25%+64.16%−0.91%

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 2 Sept 2026 · 76 securities · top-10 weight = 39.0%
Top holdingsWeight
PHILLIPS4.8%
MICROSOFT4.7%
CORECIVIC REIT4.6%
ELI LILLY4.4%
COSTCO WHOLESALE CORP4.3%
AMAZON COM INC4.1%
NOKIA3.9%
FORTINET3.5%
REGENCY CENTERS REIT CORP2.3%
CARDINAL HEALTH2.3%

Listing venues

ESMA register (FIRDS) and official exchange lists
XLPE · Borsa Italiana (ETFplus), Xetra (Deutsche Börse)
· Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
+ 20 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · etf.dws.com/download/asset/50753ce9-92b5-414e-a30c-e4bf33fd19b6
Factsheet · etf.dws.com/download/asset/bbabacb3-5c3d-4f0f-a79d-87adacd4c772
Prospectus · etf.dws.com/download/asset/97f28cea-2f24-445d-b135-f9c31a5f884d
The live sheet, always up to date
rebalix.com/en/etf/LU0322250712
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · LU0322250712 · LU03222507122